MondegarAI
Long Corridor Asset Management Ltd

Q4 2024 · 13F-HR

Long Corridor Asset Management Ltdholdings as filed

Filed 2025-02-12 · accession 0001845501-25-000002

$133.2M
Reported value
20
Positions
2024-12-31
Period end
View analyzed profile →PRO

Holdings as filed

CUSIPTickerIssuerValue% port.SharesClassVoting
45337C102INCYINCYTE CORP$22.8M17.1%330,000CommonSOLE
02079K305GOOGLALPHABET INC$20.8M15.6%110,000CommonSOLE
30303M102METAMETA PLATFORMS INC$19.3M14.5%33,000CommonSOLE
62914VAF3NIO 0.5 02/01/27NIO INC$14.8M11.1%15,000,000CommonSOLE
01609W102BABAALIBABA GROUP HLDG LTD$10.2M7.64%120,000CommonSOLE
025816109AXPAMERICAN EXPRESS CO$7.4M5.57%25,000CommonSOLE
81141R100SESEA LTD$5.3M3.98%50,000CommonSOLE
056752108BIDUBAIDU INC$5.1M3.80%60,000CommonSOLE
650111107NYTNEW YORK TIMES CO$4.7M3.52%90,000CommonSOLE
143658300CCL1EURCARNIVAL CORP$4.4M3.27%175,000CommonSOLE
98954M101ZGZILLOW GROUP INC$4.2M3.16%59,395CommonSOLE
64110W102NTESNETEASE INC$3.6M2.68%40,000CommonSOLE
62914VAK2NIO 4.625 10/15/30NIO INC$3.5M2.59%5,000,000CommonSOLE
07725L102ONCBEIGENE LTD$3.4M2.55%18,400CommonSOLE
948596101WBWEIBO CORP$3.0M2.28%318,555CommonSOLE
61225M102GLUEMONTE ROSA THERAPEUTICS INC$277,6000.21%40,000CommonSOLE
230031106CGEMCULLINAN THERAPEUTICS INC$182,7000.14%15,000CommonSOLE
87164F105SNDXSYNDAX PHARMACEUTICALS INC$132,2000.10%10,000CommonSOLE
50127T109KURAKURA ONCOLOGY INC$87,1000.07%10,000CommonSOLE
68217N105OMEGA THERAPEUTICS INC$63,3760.05%85,000CommonSOLE

Source: SEC EDGAR · raw 13F holdings as filed. The Class column shows the option type when reported (Put/Call) or Common when the issuer's equity is held directly. 13F discloses long positions only.